Fox Corporation Other Income (Expense) decreased by 209.9% to -$499.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 215.8%, from -$158.00M to -$499.00M. Over 3 years (FY 2022 to FY 2025), Other Income (Expense) shows an upward trend with a -4.9% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $69.00M | -$211.00M | -$233.00M | -$134.00M | -$76.00M | $73.00M | -$719.00M | $0.00 | -$166.00M | -$46.00M | $242.00M | -$77.00M | $233.00M | $81.00M | -$158.00M | $282.00M | -$125.00M | -$161.00M | -$499.00M |
| QoQ Change | — | -405.8% | -10.4% | +42.5% | +43.3% | +196.1% | <-999% | +100.0% | — | +72.3% | +626.1% | -131.8% | +402.6% | -65.2% | -295.1% | +278.5% | -144.3% | -28.8% | -209.9% |
| YoY Change | — | — | — | — | -210.1% | +134.6% | -208.6% | +100.0% | -118.4% | -163.0% | +133.7% | — | +240.4% | +276.1% | -165.3% | +466.2% | -153.6% | -298.8% | -215.8% |